Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells

被引:179
作者
Schmitz, Frank [1 ]
Heit, Antje [1 ]
Dreher, Stefan [1 ]
Eisenaecher, Katharina [2 ]
Mages, Joerg [1 ]
Haas, Tobias [1 ]
Krug, Anne [2 ]
Janssen, Klaus-Peter [3 ]
Kirschning, Carsten J. [1 ]
Wagner, Hermann [1 ]
机构
[1] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-8000 Munich, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Chirurg Klin & Poliklin, D-8000 Munich, Germany
关键词
Caspase-1; IRF; mTOR; TLR;
D O I
10.1002/eji.200838761
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mToR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1 beta. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1 beta. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.
引用
收藏
页码:2981 / 2992
页数:12
相关论文
共 48 条
[1]   INHIBITION OF HUMAN B-LYMPHOCYTE CELL-CYCLE PROGRESSION AND DIFFERENTIATION BY RAPAMYCIN [J].
AAGAARDTILLERY, KM ;
JELINEK, DF .
CELLULAR IMMUNOLOGY, 1994, 156 (02) :493-507
[2]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[3]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[4]   Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site [J].
Ali, SM ;
Sabatini, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :19445-19448
[5]   Akt decreases lymphocyte apoptosis and improves survival in sepsis [J].
Bommhardt, U ;
Chang, KC ;
Swanson, PE ;
Wagner, TH ;
Tinsley, KW ;
Karl, IE ;
Hotchkiss, RS .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7583-7591
[6]   Bcl-2 and Bcl-XL regulate proinf lammatory caspase-1 activation by interaction with NALP1 [J].
Bruey, Jean-Marie ;
Bruey-Sedano, Nathalie ;
Luciano, Frederic ;
Zhai, Dayong ;
Balpai, Ruchi ;
Xu, Chunyan ;
Kress, Christina L. ;
Bailly-Maitre, Beatrice ;
Li, Xiaoqing ;
Osterman, Andrei ;
Matsuzawa, Shu-ichi ;
Terskikh, Alexey V. ;
Faustin, Benjamin ;
Reed, John C. .
CELL, 2007, 129 (01) :45-56
[7]   The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway [J].
Buchkovich, Nicholas J. ;
Yu, Yongjun ;
Zampieri, Carisa A. ;
Alwine, James C. .
NATURE REVIEWS MICROBIOLOGY, 2008, 6 (04) :265-275
[8]   Translational control of the innate immune response through IRF-7 [J].
Colina, Rodney ;
Costa-Mattioli, Mauro ;
Dowling, Ryan J. O. ;
Jaramillo, Maritza ;
Tai, Lee-Hwa ;
Breitbach, Caroline J. ;
Martineau, Yvan ;
Larsson, Ola ;
Rong, Liwei ;
Svitkin, Yuri V. ;
Makrigiannis, Andrew P. ;
Bell, John C. ;
Sonenberg, Nahum .
NATURE, 2008, 452 (7185) :323-U2
[9]   Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? [J].
Corradetti, M. N. ;
Guan, K-L .
ONCOGENE, 2006, 25 (48) :6347-6360
[10]   mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex [J].
Cunningham, John T. ;
Rodgers, Joseph T. ;
Arlow, Daniel H. ;
Vazquez, Francisca ;
Mootha, Vamsi K. ;
Puigserver, Pere .
NATURE, 2007, 450 (7170) :736-U12